Galatek is building hardware and software for two of the most exacting environments in industrial tech: the life sciences laboratory and the semiconductor fab. The Singapore-based company, founded in 2025, announced a $30 million Series A in December of that year to scale its Abio platform, which combines laboratory information systems, electronic notebooks, and robotic automation [PR Newswire, December 2025]. Its parallel product line for semiconductors includes deep-learning optical inspection and precision wafer-dicing systems [Semiconductor Engineering, January 2026]. The bet is that a single company can deliver the vision AI, motion control, and data integrity required for both markets.
The Dual-Market Wedge
The company's positioning is unusual. Most automation specialists focus on a single vertical, but Galatek is targeting two distinct, high-precision domains. In life sciences, the Abio platform is described as an integrated system for smart laboratories, unifying Laboratory Information Management (LIMS) and Electronic Notebooks (ELN) with hardware automation [AIPressRoom, Unknown]. For semiconductor manufacturing, the products are geared toward metrology, inspection, and advanced packaging. The technical overlap lies in the need for reproducible workflows, sub-micron accuracy, and traceable data. By developing a core stack of vision AI and motion control, Galatek aims to apply it across these fields, though the specific hardware end-effectors and software interfaces would differ.
Traction and Expansion
Galatek has reported early collaborations, including co-creating smart laboratories with the National University of Singapore [PR Newswire, December 2025]. The company also states it is working with unnamed global pharmaceutical firms and semiconductor manufacturers. The most concrete signal of commitment is a physical expansion: in June 2026, Galatek opened a plant in Penang, Malaysia, with a target investment of $100 million focused on Malaysia-origin exports [Digital News Asia, June 2026]. This move suggests a strategy to build manufacturing capacity closer to key semiconductor supply chains in Southeast Asia. David Tian is identified as the company's CEO [LinkedIn, retrieved 2026].
Technical Breakdown and Scale Risks
The core technical challenge for Galatek is not the individual components,vision systems and robotic arms are commodities,but the integration layer. A laboratory sample handler and a wafer inspection robot have vastly different failure modes and contamination protocols. The Abio platform's value hinges on its ability to abstract these complexities into a unified software layer that manages both data and motion reliably.
At scale, two primary risks emerge. First, market focus. Serving two sophisticated, regulated industries simultaneously risks diluting engineering resources and go-to-market focus. A bug fix for a biotech client's incubator has no bearing on a fab's overlay measurement system. Second, validation cycles. Sales into pharmaceutical R&D and semiconductor production lines involve long qualification periods and entrenched incumbents like Thermo Fisher Scientific or KLA. Galatek's reported partnerships are unnamed, making it difficult to assess the depth of these integrations. The company's answer appears to be capital intensity, using its Series A and plant investment to build a physical footprint that demonstrates serious commitment to both sectors.
Sources
- [PR Newswire, December 2025] SG-based Startup Galatek Raises $30M Series A to Accelerate AI-powered Automation | https://www.prnewswire.com/apac/news-releases/sg-based-startup-galatek-raises-30m-series-a-to-accelerate-ai-powered-automation-in-life-sciences-and-semiconductor-manufacturing-302646550.html
- [Semiconductor Engineering, January 2026] Startup Funding: Q4 2025 | https://semiengineering.com/startup-funding-q4-2025/
- [AIPressRoom, Unknown] Galatek Raises $30M for Precision Automation | https://aipressroom.com/galatek-30m-precision-automation/
- [Digital News Asia, June 2026] MegaRobo-linked Galatek Technologies opens Penang plant | https://www.digitalnewsasia.com/business/megarobo-linked-galatek-technologies-opens-penang-plant-target-us100m-investment-and
- [LinkedIn, retrieved 2026] David Tian profile | https://www.linkedin.com/in/glendoncheok/